Supported by The Pandemic Institute, and based at the University of Liverpool, the Pre-Clinical Studies Unit offers world leading expertise and technical know-how in testing new vaccine candidates, therapeutics, drugs, small molecules and other experimental therapies, using clinically relevant in vitro and in vivo models. In addition to offering established models of infectious disease, our in-house expertise and infrastructure allow us to pivot rapidly to new and emerging infections and develop relevant new models.
The Pandemic Institute
The Pandemic Institute
Clinically relevant models of infection and disease for testing new vaccine candidates, drugs and therapies
For further information, download the brochure below, or get in touch on the following:
Professor Aras Kadioglu, Director of The Pre-Clinical Studies Unit
[email protected]
Partnerships Team, The Pandemic Institute
[email protected]
What we offer
High quality pre-clinical immunogenicity and efficacy data on vaccine candidates, novel experimental therapeutics and other treatments. For further details please download our brochure.
Download the brochure Sign up to our newsletter
Join our mailing list to hear about our latest news, events and funding opportunities.
